Position in MRK
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$565,785
+$78,731 QoQ
Shares Held
4,403
+8.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#2,590
of 3,768 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EWA, LLC holds $7,685,441 across 8 Drug Manufacturers - General names. MRK ranks #4 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,662 | $3,192,882 | |
| 2 | JNJ |
Johnson & Johnson
|
4,511 | $1,145,658 | |
| 3 | ABBV |
AbbVie Inc.
|
3,645 | $917,227 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
4,403 | $565,785 | |
| 5 | AZN |
Astrazeneca PLC
|
2,740 | $519,558 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,938 | $497,526 | |
| 7 | NVS |
Novartis AG
|
2,790 | $437,248 | |
| 8 | AMGN |
Amgen Inc
|
1,131 | $409,557 |
All Filings in MRK
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $565,785 | 4,403 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $487,054 | 4,049 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $338,095 | 3,212 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $220,735 | 2,630 | Shares | Sole | 2025-10-31 | |
| 2024-12-31 | $343,007 | 3,448 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $255,282 | 2,248 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $358,648 | 2,897 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $292,005 | 2,213 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||